SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $41,000 | +86.4% | 208 | +58.8% | 0.01% | +80.0% |
| Q2 2020 | $22,000 | -56.0% | 131 | -70.0% | 0.01% | -37.5% |
| Q1 2020 | $50,000 | -12.3% | 437 | -14.5% | 0.01% | +14.3% |
| Q4 2019 | $57,000 | +35.7% | 511 | 0.0% | 0.01% | +16.7% |
| Q3 2019 | $42,000 | +281.8% | 511 | +215.4% | 0.01% | +200.0% |
| Q2 2019 | $11,000 | -81.7% | 162 | -80.9% | 0.00% | -81.8% |
| Q1 2019 | $60,000 | +566.7% | 850 | +424.7% | 0.01% | +450.0% |
| Q4 2018 | $9,000 | -25.0% | 162 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $12,000 | +20.0% | 162 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $10,000 | +25.0% | 162 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $8,000 | 0.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | 0.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | 0.0% | 162 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $8,000 | -20.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $10,000 | +25.0% | 162 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $8,000 | 0.0% | 162 | 0.0% | 0.00% | -20.0% |
| Q3 2016 | $8,000 | +33.3% | 162 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $6,000 | – | 162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |